跳至主要内容
临床试验/CTRI/2025/02/080846
CTRI/2025/02/080846尚未招募3 期

Comparative study of analgesic efficacy between addition of dexmedetomidine or magnesium sulphate with Ropivicaine in Quadratus lumborum block for endoscopic Inguinal Hernia Repair.

Banaras Hindu University1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2025年2月27日最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
75
试验地点
1
主要终点
VAS score will be monitored

研究概览

简要总结

After obtaining the institutional ethical committee approval and written informed consent from the participants, they will be enrolled into our study.

A total of 90 participants will be enrolled and randomized into two equal groups of 30 each.

Group A (ROPIVICAINE WITH MAGNESIUM SULPHATE):

Ultrasound guided QL2 block with 30ml of Inj. Ropivacaine 0.375% +Inj .Magnesium sulphate 400mg

Group B (ROPIVICAINE WITH DEXMEDETOMIDINE):

Ultrasound guided QL2 block with 30ml of Inj. Ropivacaine 0.375% + Inj.Dexmedetomidine 50mcg

CONTROL GROUP C (ROPIVICAINE):

Ultrasound guided QL2 block with 30ml of Inj.Ropivicaine 0.375%

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 56.00 Year(s)(—)
性别
All

入选标准

  • Patients having uncomplicated inguinal hernia -Age more than 18- 56 years.
  • American society of Anaesthesiologists grade I and II patients -Written and informed consent.

排除标准

  • Patient with known coagulopathy.
  • Patients allergic to the study drug.
  • Patients with hepatic or renal dysfunction.
  • Patients with history of receiving anticoagulant treatment.
  • Patients having history of chronic opioid consumption.

结局指标

主要结局

VAS score will be monitored

时间窗: Post procedure outcomes are assesed at 0min, 15 minutes, 1 hour, 2 hours,6hours, 12 hours, 24 hours post-operatively.

次要结局

  • Time for requirement of first rescue analgesia will be noted.(Post procedure rescue analgesia assesed till 24 hours)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Keshav Ram S

Institute Of Medical Sciences

研究点 (1)

Loading locations...

相似试验